1. Home
  2. BALY vs SYRE Comparison

BALY vs SYRE Comparison

Compare BALY & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BALY
  • SYRE
  • Stock Information
  • Founded
  • BALY 2004
  • SYRE 2013
  • Country
  • BALY United States
  • SYRE United States
  • Employees
  • BALY 10000
  • SYRE N/A
  • Industry
  • BALY Hotels/Resorts
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BALY Consumer Discretionary
  • SYRE Health Care
  • Exchange
  • BALY Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • BALY 737.4M
  • SYRE 841.4M
  • IPO Year
  • BALY N/A
  • SYRE 2016
  • Fundamental
  • Price
  • BALY $9.91
  • SYRE $17.79
  • Analyst Decision
  • BALY Hold
  • SYRE Buy
  • Analyst Count
  • BALY 7
  • SYRE 5
  • Target Price
  • BALY $18.00
  • SYRE $55.00
  • AVG Volume (30 Days)
  • BALY 363.4K
  • SYRE 591.7K
  • Earning Date
  • BALY 02-19-2025
  • SYRE 08-06-2025
  • Dividend Yield
  • BALY N/A
  • SYRE N/A
  • EPS Growth
  • BALY N/A
  • SYRE N/A
  • EPS
  • BALY N/A
  • SYRE N/A
  • Revenue
  • BALY $2,481,783,000.00
  • SYRE N/A
  • Revenue This Year
  • BALY $3.06
  • SYRE N/A
  • Revenue Next Year
  • BALY N/A
  • SYRE N/A
  • P/E Ratio
  • BALY N/A
  • SYRE N/A
  • Revenue Growth
  • BALY 2.80
  • SYRE N/A
  • 52 Week Low
  • BALY $9.74
  • SYRE $10.91
  • 52 Week High
  • BALY $18.38
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • BALY 46.11
  • SYRE 61.20
  • Support Level
  • BALY $9.70
  • SYRE $16.16
  • Resistance Level
  • BALY $10.25
  • SYRE $18.31
  • Average True Range (ATR)
  • BALY 0.61
  • SYRE 0.96
  • MACD
  • BALY -0.06
  • SYRE 0.20
  • Stochastic Oscillator
  • BALY 20.50
  • SYRE 84.18

About BALY Bally's Corporation

Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: